VIC 2022 Mid-Year Update Executive Summary

The first half of the year has been exciting for VIC and our portfolio companies, including new pre-clinical and clinical milestones reached, products released to market, recent funding, and more Click Here to download...

Inside CTTC at Vanderbilt University with Assistant Director, Physical Sciences Ashok Choudhury

Tell us about your background in technology transfer and commercialization. What experiences led you to this role? During my role as a researcher at a national laboratory, I worked at a DOE “User Center” where I had the...

VIC Tech Announces New Class of Fellows

The VIC Tech investment model is unique; it sources promising life science innovation directly from universities across the nation, allocating funding to form startup companies and advance these technologies to exit via...

Cellia Science Announces Dr. Wilbur Lam as Chief Medical Officer

Dr. Lam brings clinical and technical expertise to hematology analyzer development at Cellia Science Fayetteville, AR - Cellia Science, Inc., announced today the appointment of Wilbur Lam, MD, PhD, as Chief Medical...

CardioWise Joins the Lucem Health Innovation Collaborative as a Founding Member

Bringing AI/ML to the Front Lines of Healthcare Fayetteville, AR - CardioWise® and Lucem Health™ announced that CardioWise has become a founding member of the Lucem Health Innovation Collaborative, a partner program...

Challenges and Solutions for University Technology Commercialization (Part 1)

The honest truth? Deciding which early-stage technologies will be successful is really hard. This is even more the case when you add the challenges faced in a university setting. Although I’m currently on the investment...

VIC Tech Grows Its Medical Advisory Board

VIC Tech is pleased to announce the addition of five new members to its Medical Advisory Board to help guide VIC with additional domain expertise across a variety of life science disciplines. MAB members support VIC’s...

From the Corner Office: Filtravate

“We can’t change the whole world, but let’s try to work to make our corner of it better.”  COVID-19 didn't happen in a vacuum, as our globe has several comorbidities occurring in tandem; global warming, clean water...

Cellia Science Formed to Develop and Commercialization Point-of-Care Hematology Analyzers

New company to advance blood cell analysis using label-free deep-UV imaging Fayetteville, AR - VIC Technology Venture Development, LLC (VIC) announced today the formation of Cellia Science, Inc., to develop and...

VIC Fellows Spotlight: Cristhiaan Ochoa, MD, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

SAFE vs. Convertible Notes: Which is a Better Choice for Early-Stage Investments?

Experienced early-stage investors are familiar with convertible note investments, which have evolved slightly but have been around in largely the same form for more than two decades. Convertible note investments start...

Solenic CEO James Lancaster presents at the LSI Emerging Medtech Summit

Leaders in the MedTech market gather at the global Emerging Medtech Summit event, filled with industry-leading innovators, investors, and strategics. During the event, Solenic Medical CEO James Lancaster shares how...

From the Corner Office: Neurexis Therapeutics

Let me start by saying that the last two years have been a case study on focusing on priorities and filtering out noise. I’m fortunate to work in an area where it’s easy to see the long-term value of what we...

Inside CSURF with Managing Director, Steve Foster

Please describe your background After my undergrad in Biological Sciences, I spent 13 years at Amgen in Thousand Oaks, CA. After 11 years in the lab, I wanted to try something different and ended up in the Corporate...

Filtravate Highlighted by The Business Journals

A Las Cruces startup developing a production process for tunable water filters is raising its seed funding round. The startup, Filtravate, utilizes technology licensed from New Mexico State University. Angel investors...

VIC Fellows Spotlight: Gurshagan Kandhola, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

VIC 2021 Annual Report Executive Summary

2021 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.

VIC Technology Venture Development Establishes Medical Advisory Board

VIC’s newly formed Medical Advisory Board (MAB) provides VIC with additional domain expertise across a variety of life science disciplines. MAB members support VIC’s opportunity assessment team by reviewing new...

Letter from the CEO

It has been a year and ten months since the World Health Organization declared COVID-19 a pandemic. Despite the continuing pandemic, VIC’s business has largely returned to normal albeit with increased remote work, more...

FEATURED RESOURCES

Updates
VIC 2021 Annual Report Executive Summary
Insight
Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside UCSF Innovation Ventures with Executive Director, Anthony Francis
Insight
Protecting Early Investors in Capital-Intensive Life Science Companies
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
Interview
VIC Fellows Spotlight: Kelly Mabry, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission